Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis

“Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis… Cannabinoids exert neuroprotective and symptomatic effects in amyotrophic lateral sclerosis (ALS)…”

http://www.ncbi.nlm.nih.gov/pubmed/22594565  

Rheumatoid arthritis, cannabis based medicine eases pain and suppresses disease

“The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease”

http://www.medicalnewstoday.com/releases/33376.php

The Cannabinergic System as a Target for Anti-inflammatory Therapies

“Cell-based experiments or in vivo animal testing suggest that regulation of the endocannabinoid circuitry can impact almost every major function associated with the immune system. These studies were assisted by the development of numerous novel molecules that exert their biological effects through the endocannabinoid system. Several of these compounds were tested for their effects on immune function, and the results suggest therapeutic opportunities for a variety of inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, atherosclerosis, allergic asthma, and autoimmune diabetes through modulation of the endocannabinoid system.”

http://www.ingentaconnect.com/content/ben/ctmc/2006/00000006/00000013/art00008

Marijuana Slows Alzheimer’s Decline

“the investigators confirmed that cannabinoids counteracted the activation of microglia and thus reduced inflammation.  These findings that cannabinoids work both to prevent inflammation and to protect the brain may set the stage for their use as a therapeutic approach for Alzheimer’s disease, de Ceballos said.”

http://www.mapinc.org/drugnews/v05/n307/a10.html